Article
Computational modeling and optimization of peptide-based CAR-T cell receptors targeting CD19 for enhanced efficacy and minimized toxicity
2025-03-14
Abstract excerpt
<title>Abstract</title> <p>Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of B-cell malignancies, with CD19 being a primary target due to its stable expression in lymphomas. However, current CAR-T therapies face challenges related to antigen escape, treatment resistance, and toxicity. In this study, we employed a computational approach to design and optimize peptide-based CAR-T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6de54ab1-6534-5d75-90e3-fa1ba5a6af2c
- DOI
- 10.21203/rs.3.rs-6115435/v2
